Role of Interleukin-5 in the Pathophysiology and Treatment of Eosinophilic Asthma

Authors

  • Nightingale Syabbalo

Keywords:

eosinophilic asthma, cytokines, interleukin-5, monoclonal antibodies

Abstract

Asthma is a heterogeneous chronic airway disease with several distinct phenotypes characterized by different immune pathological pathways, clinical features, disease severity, physiology, and response to treatment. Approximately 50% of patients with stable chronic asthma have the eosinophilic phenotype, whereas the remainder have the non-eosinophilic asthma. Eosinophilic asthma is the most common phenotype in children with acute severe asthma, but neutrophilic asthma is the most common in adult patients presenting with acute severe asthma.

How to Cite

Nightingale Syabbalo. (2020). Role of Interleukin-5 in the Pathophysiology and Treatment of Eosinophilic Asthma. Global Journal of Medical Research, 20(F9), 27–40. Retrieved from https://medicalresearchjournal.org/index.php/GJMR/article/view/2235

Role of Interleukin-5 in the Pathophysiology and Treatment of Eosinophilic Asthma

Published

2020-08-15